Daily Archives: October 31, 2006

Antibiotics and Clinical Trials

Posted on October 31, 2006 by Mark Senak

What happens when the FDA decides on new policies during the course of a clinical trial?  Last week, Replidyne and Forest Laboratories reported that the FDA issued a non-approvable letter for Faropenem, an antibiotic.  The FDA wanted further clinical studies … Continue reading →

Posted in Clinical Trials | 1 Comment